Destruction of a destructor: A new avenue for cancer therapeutics targeting the Wnt pathway

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

A new study in Nature has identified a small molecule inhibitor for the oncogenic Wnt/β-catenin pathway that is responsible for many human cancers. This inhibitor targets an unsuspected cellular enzyme, Tankyrase, which controls the destruction of a β-catenin destructor.

Original languageEnglish
Pages (from-to)70-73
Number of pages4
JournalJournal of Molecular Cell Biology
Volume2
Issue number2
DOIs
StatePublished - 2010

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'Destruction of a destructor: A new avenue for cancer therapeutics targeting the Wnt pathway'. Together they form a unique fingerprint.

Cite this